98 related articles for article (PubMed ID: 12785400)
1. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.
Edmond M
Infect Control Hosp Epidemiol; 2003 May; 24(5):309-10; author reply 310-2. PubMed ID: 12785400
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.
Muto CA; Giannetta ET; Durbin LJ; Simonton BM; Farr BM
Infect Control Hosp Epidemiol; 2002 Aug; 23(8):429-35. PubMed ID: 12186207
[TBL] [Abstract][Full Text] [Related]
3. Use of active surveillance cultures to control vancomycin-resistant Enterococcus.
Diekema DJ
Clin Infect Dis; 2003 Nov; 37(10):1400-2; author reply 1402-3. PubMed ID: 14583882
[No Abstract] [Full Text] [Related]
4. Infection control can help keep VRE in check.
Steele T
Nephrol News Issues; 1999 May; 13(5):37. PubMed ID: 10578822
[No Abstract] [Full Text] [Related]
5. Control of nosocomial acquisition of vancomycin-resistant Enterococcus through active surveillance of hemodialysis patients.
Axon RN; Engemann JJ; Butcher J; Lockamy K; Kaye KS
Infect Control Hosp Epidemiol; 2004 May; 25(5):436-8. PubMed ID: 15188852
[TBL] [Abstract][Full Text] [Related]
6. Control of vancomycin-resistant enterococci: it is important, it is possible, and it is cost-effective.
Mayhall CG
Infect Control Hosp Epidemiol; 2002 Aug; 23(8):420-3. PubMed ID: 12186205
[No Abstract] [Full Text] [Related]
7. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?
Puzniak LA; Gillespie KN; Leet T; Kollef M; Mundy LM
Infect Control Hosp Epidemiol; 2004 May; 25(5):418-24. PubMed ID: 15188849
[TBL] [Abstract][Full Text] [Related]
8. Politically incorrect: legislation must not mandate specific healthcare epidemiology and infection prevention and control practices.
Fraser V; Murphy D; Brennan PJ; Frain J; Arias KM; Perl TM;
Infect Control Hosp Epidemiol; 2007 May; 28(5):594-5. PubMed ID: 17464921
[No Abstract] [Full Text] [Related]
9. Political versus epidemiological correctness.
Farr BM
Infect Control Hosp Epidemiol; 2007 May; 28(5):589-93. PubMed ID: 17464920
[No Abstract] [Full Text] [Related]
10. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
Farr BM
Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
[No Abstract] [Full Text] [Related]
11. Epidemiology of enterococci in a neonatal intensive care unit.
Duchon J; Graham Iii P; Della-Latta P; Whittier S; Carp D; Bateman D; Saiman L
Infect Control Hosp Epidemiol; 2008 Apr; 29(4):374-6. PubMed ID: 18462152
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
Yiş R; Aslan S; Cıtak C; Değirmenci S
Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
[TBL] [Abstract][Full Text] [Related]
13. A guide to TB, VRE, and MRSA.
RN; 1998 Jul; 61(7):24DD. PubMed ID: 9687812
[No Abstract] [Full Text] [Related]
14. Vancomycin resistant enterococci healthcare associated infections.
Orsi GB; Ciorba V
Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
[TBL] [Abstract][Full Text] [Related]
15. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
Humphreys H
J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
[No Abstract] [Full Text] [Related]
16. Control of vancomycin-resistant enterococci in the neonatal intensive care unit.
Singh N; Léger MM; Campbell J; Short B; Campos JM
Infect Control Hosp Epidemiol; 2005 Jul; 26(7):646-9. PubMed ID: 16092746
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance.
DeLisle S; Perl TM
Chest; 2003 May; 123(5 Suppl):504S-18S. PubMed ID: 12740236
[TBL] [Abstract][Full Text] [Related]
18. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
[TBL] [Abstract][Full Text] [Related]
19. VRE. How you can stop the spread of this drug-resistant organism.
Cooper E
RN; 2008 Feb; 71(2):27-31; quiz 32. PubMed ID: 18386441
[No Abstract] [Full Text] [Related]
20. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.
Ofner-Agostini M; Johnston BL; Simor AE; Embil J; Matlow A; Mulvey M; Ormiston D; Conly J;
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):271-4. PubMed ID: 18241031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
